Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Oliver Stoetzer"'
Autor:
Ugur Gezer, Angela Oberhofer, Karolina Worf, Oliver Stoetzer, Stefan Holdenrieder, Abel Bronkhorst
Publikováno v:
Diagnostics, Vol 14, Iss 6, p 609 (2024)
Liquid biopsies are revolutionizing the detection and management of malignant diseases. While repetitive DNA sequences, such as LINE-1 and ALU are established in cell-free DNA (cfDNA) research, their clinical applications remain limited. In this stud
Externí odkaz:
https://doaj.org/article/41b1474cd01b41d6b50bc765749a810f
Autor:
Peyman Hadji, Oliver Stoetzer, Thomas Decker, Christian M. Kurbacher, Frederik Marmé, Andreas Schneeweiss, Christoph Mundhenke, Andrea Distelrath, Peter A. Fasching, Michael P. Lux, Diana Lüftner, Wolfgang Janni, Mathias Muth, Julia Kreuzeder, Claudia Quiering, Eva-Marie Grischke, Hans Tesch
Publikováno v:
Journal of Bone Oncology, Vol 14, Iss , Pp - (2019)
Background: Breast cancer and its treatments are associated with a detrimental effect on bone health. Here we report the results of an exploratory analysis assessing changes in levels of biomarkers of bone metabolism in patients enrolled in the phase
Externí odkaz:
https://doaj.org/article/c2654a29bfbd4af0b90b6c2e4cd0ef03
Autor:
Helga Schmetzer, Oliver Stoetzer, Joerg Uwe Schmohl, Helmut R. Salih, Amely Hartmann, Thomas Guenther, Friedhelm R. Schuster, Tanja Kroell, Wishnu Sutanto
Publikováno v:
Immunobiology. 226(1)
The High Mobility Group Box 1 (HMGB1) is a nuclear protein that is frequently overexpressed in hematologic diseases and might be of relevance in immunogenic cancer control thus correlating with patients' (pts.) prognosis in diseases such as acute mye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d9e0bd899c39dd22a62d3db9a519023
https://pubmed.ncbi.nlm.nih.gov/33485134
https://pubmed.ncbi.nlm.nih.gov/33485134
Autor:
Gerald Grütz, Marlies Michl, Martin K. Angele, Dominik Paul Modest, Volker Heinemann, Sylvia Peter, Peter J. Nelson, Christine Günther, Christiane Bruns, Hanno Niess, Hans-Dieter Volk, Oliver Stoetzer, Christoph Salat, Julian Walter Holch, Jobst C. von Einem
Publikováno v:
Oncotarget
// Jobst C. von Einem 1 , Sylvia Peter 2 , Christine Gunther 2 , Hans-Dieter Volk 3 , Gerald Grutz 3 , Christoph Salat 4 , Oliver Stoetzer 4 , Peter J. Nelson 5 , Marlies Michl 1 , Dominik P. Modest 1 , Julian W. Holch 1 , Martin Angele 6 , Christian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f29a3a0dbd18bc47dc9694b3a4d029c
http://europepmc.org/articles/PMC5655186
http://europepmc.org/articles/PMC5655186
Autor:
Oliver Stoetzer, Christoph Mundhenke, Eva-Marie Grischke, Peyman Hadji, Wolfgang Janni, Hans Tesch, Frederik Marmé, Christian M. Kurbacher, Thomas Decker, Andreas Schneeweiss, Diana Lüftner, Mathias Muth, J Kreuzeder, Peter A. Fasching, Andrea Distelrath, Michael P. Lux, Claudia Quiering
Publikováno v:
Journal of Bone Oncology, Vol 14, Iss, Pp-(2019)
Journal of Bone Oncology
Journal of Bone Oncology
Background: Breast cancer and its treatments are associated with a detrimental effect on bone health. Here we report the results of an exploratory analysis assessing changes in levels of biomarkers of bone metabolism in patients enrolled in the phase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a73681b464a067ac437a316637b7981
https://pubmed.ncbi.nlm.nih.gov/30515367
https://pubmed.ncbi.nlm.nih.gov/30515367
Autor:
Diana Lüftner, Wolfgang Janni, Peyman Hadji, Hans Tesch, Micheal P Lux, J Kreuzeder, Oliver Stoetzer, Christoph Mundhenke, Peter A. Fasching, Romy Neumeister, Thomas Decker, Frederik Marmé, Christian M. Kurbacher, Andreas Schneeweiss, Mathias Muth, Claudia Weiss, Andrea Distelrath, Eva-Maria Grischke
Publikováno v:
Cancer Research. 75:P3-06
Introduction: The BOLERO-2 study showed significant doubling of PFS benefit with the addition of EVE to EXE in postmenopausal women with hormone receptor–positive advanced breast cancer progressing after non-steroidal aromatase inhibitor (NSAI) the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2201735ef3d9d8ac0e53fa3d66439b22
https://doi.org/10.1158/1538-7445.sabcs14-p3-06-04
https://doi.org/10.1158/1538-7445.sabcs14-p3-06-04
Autor:
Hans-Jochem Kolb, Christine Waterhouse, Georg Ledderose, Oliver Stoetzer, Michael Schleuning, Markus Schlemmer
Publikováno v:
Experimental Hematology. 30:7-10
Objective Sickle cell disease generates considerable morbidity and mortality. Allogeneic hematopoietic stem cell transplantation (SCT) has the potential of curing the disease and halting end-organ damage. However, in older patients this treatment is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a34069dded53fa9b6e60730234752a
https://doi.org/10.1016/s0301-472x(01)00775-5
https://doi.org/10.1016/s0301-472x(01)00775-5
Publikováno v:
Anticancer research. 32(5)
Circulating nucleosomes are valuable biomarkers for therapy monitoring and estimation of prognosis in cancer disease. While epigenetic and genetic modifications of DNA have been reported in blood of cancer patients, little is known about modification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::659d33a953cc0cd05247a3d69441f064
https://pubmed.ncbi.nlm.nih.gov/22593510
https://pubmed.ncbi.nlm.nih.gov/22593510